Concepedia

Murali Gopalakrishnan

MG

Statistics

Publications

104

Citations

5.7K

H-Index

44

Active since

1990

Affiliations

Abbott Fund(Current)

Abbott (United States)

Abbott (United Kingdom)

Discovery Laboratories (United States)

Murali Gopalakrishnan is an author at Abbott Fund specializing in pharmacology, neuroscience, and neuropharmacology.

ORCID

Publications per year

1990–2018

104

Publications

104

Distinct Profiles of α7 nAChR Positive Allosteric Modulation Revealed by Structurally Diverse Chemotypes

Jens Halvard Grønlien, Monika Håkerud, Hilde Ween et al. · Molecular Pharmacology · 2007 · 272 citations

, , +17

Allosteric modulation of nicotinic acetylcholine receptors

Daniel Bertrand, Murali Gopalakrishnan · Biochemical Pharmacology · 2007 · 251 citations

, , +14

An Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor Possessing Cognition-Enhancing Properties in Vivo

Daniel B. Timmermann, Jens Halvard Grønlien, Kathy L. Kohlhaas et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 214 citations

, , +17

Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo

Clark A. Briggs, David J. Anderson, Jorge D. Brioni et al. · Pharmacology Biochemistry and Behavior · 1997 · 192 citations

, , +12

Broad-Spectrum Efficacy across Cognitive Domains by α7 Nicotinic Acetylcholine Receptor Agonism Correlates with Activation of ERK1/2 and CREB Phosphorylation Pathways

Robert S. Bitner, William H. Bunnelle, David J. Anderson et al. · Journal of Neuroscience · 2007 · 185 citations · Full text

, , +17

1–5 of 104